Myomo Insider Files Form 144 for $51.7K Secondary Share Sale

Rhea-AI Filing Summary

Myomo, Inc. (MYO) – Form 144 filing: The notice discloses a proposed sale of 23,587 common shares by David Henry through Morgan Stanley, targeted for 30 June 2025 on the NYSE American. The shares have an aggregate market value of $51,655.53, equating to roughly 0.07 % of the company’s 35,978,922 shares outstanding, indicating an immaterial proportion of total equity.

The securities derive from the vesting of restricted stock units (RSUs) on 28 June 2025, when 65,000 shares were acquired from Myomo. In addition, the filer sold 8,373 shares on 06 June 2025 for gross proceeds of $24,867.81. No other financial data or operational commentary is provided in the filing.

Because the planned sale represents a very small percentage of outstanding shares and does not involve new share issuance, dilution is not a concern. Nonetheless, investors often monitor insider transactions for sentiment signals; repeated insider selling can be interpreted cautiously, even when associated with equity compensation events such as RSU vesting.

Positive

• No dilution risk: the filing pertains to secondary sales of already-issued shares, so share count remains unchanged.
• Small relative size: 23,587 shares represent only about 0.07 % of outstanding stock, limiting market impact.

Negative

• Continued insider selling: the filer sold 8,373 shares earlier in the quarter and plans to sell another 23,587, which can be perceived negatively for sentiment.
• Lack of contextual information: the filing provides no insights into operational performance, leaving investors without guidance on fundamentals.

Insights

Securities Analyst

TL;DR: Small insider sale (~0.07 % of shares) after RSU vesting; impact on valuation or float is negligible—sentiment effect likely minimal.

Materiality: The proposed divestiture of 23,587 shares worth about $52k is trivial relative to Myomo’s share base and therefore unlikely to influence liquidity or price discovery. The recent 8,373-share sale further underscores that the insider is gradually monetising compensation rather than executing a large strategic exit.

Valuation/Supply Dynamics: Since the shares are already outstanding, there is no dilution. Trading volume on small-cap names can vary, but the absolute share count is modest and should be readily absorbed by the market.

Sentiment Consideration: Insider disposition following RSU vesting is common. However, market participants may still view consecutive sales as a mild negative signal, especially if unaccompanied by insider purchases.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley 1 New York Plaza 38th Floor New York NY 10004	23587	51655.53	35978922	06/30/2025	NYSE American

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/28/2025	Vesting of Restricted Stock Units	Myomo, Inc.			65000	06/30/2025	Vesting of Restricted Stock Units

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Henry 45 Blue Sky Dr. Suite 101 Burlington MA 01803	Common Stock	06/06/2025	8373	24867.81

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Myomo (MYO) shares are being sold under this Form 144?

The filing covers 23,587 common shares to be sold.

What is the estimated market value of the planned MYO share sale?

The aggregate market value is listed as $51,655.53.

When is the expected sale date for these MYO shares?

The approximate date of sale is 30 June 2025.

What percentage of Myomo’s outstanding shares does this sale represent?

About 0.07 % of the 35,978,922 shares outstanding.

Has the filer sold MYO shares recently?

Yes, 8,373 shares were sold on 06 June 2025 for $24,867.81 in gross proceeds.